Heinz F X, Kunz C, Barrett N
Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Apr;264(1-2):196-200.
Eight hundred sera from a non-risk group and thousand sera from people at risk for acquiring AIDS were tested for the presence of LAV/HTLV-III specific antibodies by ELISA test kits manufactured by Du Pont and Organon. Western Blot analysis was used as a confirmatory test. All Western Blot positive sera were also positive in the Du Pont ELISA which in addition revealed a very low rate of false positive results (0.44%). In the Organon ELISA negative results were obtained with one positive and one questionable positive serum, as determined by Western Blot. The possible problem of test sensitivity being too low has been taken into account by the manufacturer by changing the calculation of cut-off values.
采用杜邦公司和欧加农公司生产的酶联免疫吸附测定(ELISA)试剂盒,对800份来自非风险人群的血清和1000份有感染艾滋病风险人群的血清进行检测,以确定是否存在淋巴细胞脉络丛脑膜炎病毒/人嗜T淋巴细胞病毒III型(LAV/HTLV-III)特异性抗体。采用蛋白质印迹分析作为确证试验。所有蛋白质印迹法检测呈阳性的血清在杜邦酶联免疫吸附测定中也呈阳性,此外该方法还显示出极低的假阳性率(0.44%)。在欧加农酶联免疫吸附测定中,根据蛋白质印迹分析,有一份阳性血清和一份可疑阳性血清结果为阴性。制造商已通过改变临界值的计算方法来考虑检测灵敏度可能过低的问题。